Cargando…
The evidence for the use of recombinant factor VIIa in massive bleeding: revision of the transfusion policy framework
In 2006, the Canadian National Advisory Committee on Blood and Blood Products (NAC) developed a transfusion policy framework for the use of off-label recombinant factor VIIa (rFVIIa) in massive bleeding. Because the number of randomised controlled trials has doubled, the NAC undertook a review of th...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Blackwell Publishing Ltd
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546370/ https://www.ncbi.nlm.nih.gov/pubmed/22630348 http://dx.doi.org/10.1111/j.1365-3148.2012.01164.x |